Unlock instant, AI-driven research and patent intelligence for your innovation.

A novel genetically engineered subunit vaccine for Mycoplasma gallisepticum

A technology of mycoplasma gallisepticum and amino acids, which is applied in the direction of vaccines, veterinary vaccines, antibody medical components, etc., can solve the problems of lack, weak immune protection of vaccines, and easy mutation of antigenic proteins, so as to achieve sufficient supply and protein immunogen Good sex and good immunogenicity

Active Publication Date: 2022-06-24
苏州沃美生物有限公司
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At the same time, during the culture process of Mycoplasma gallisepticum, due to changes in conditions such as culture temperature, medium composition and self-replication, the antigenic protein on the surface of Mycoplasma gallisepticum is prone to mutation and loss, resulting in weak immune protection of inactivated vaccines The problem

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A novel genetically engineered subunit vaccine for Mycoplasma gallisepticum
  • A novel genetically engineered subunit vaccine for Mycoplasma gallisepticum
  • A novel genetically engineered subunit vaccine for Mycoplasma gallisepticum

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0143] Example 1 Construction and identification of transfer vector pF-MGC1

[0144] 1. MGC1 gene amplification and purification The codon-optimized MGC1 gene (SEQ ID NO: 1) was synthesized in Nanjing GenScript Company and cloned into the pUC17 vector to obtain the pUC-MGC1 plasmid vector. The pUC-MGC1 plasmid was used as a template, and MGC1-F and MGC1-R were used as upstream and downstream primers for PCR amplification (the gene sequences of MGC1-F and MGC1-R are shown in SEQ ID NO. 11 and 12). The amplification system is shown in Table 1.

[0145] Table 1 MGC1 gene amplification system

[0146]

[0147] The reaction conditions were: pre-denaturation at 95°C for 5 minutes; denaturation at 94°C for 45 seconds, annealing at 54°C for 45 seconds, extension at 72°C for 1 minute, 35 cycles; extension at 72°C for 10 minutes.

[0148] The PCR product is subjected to gel electrophoresis to verify the size of the target gene, such as figure 1 As shown, the target band appeared a...

Embodiment 2

[0161] Example 2 Construction and identification of transfer vector pF-MGC2

[0162] 1. MGC2 gene amplification and purification The codon-optimized MGC2 gene (SEQ ID NO: 3) was synthesized in Nanjing GenScript Company and cloned into the pUC17 vector to obtain the pUC-MGC2 plasmid vector. The pUC-MGC2 plasmid was used as a template, and MGC2-F and MGC2-R were used as upstream and downstream primers for PCR amplification (the gene sequences of MGC2-F and MGC2-R are shown in SEQ ID NO. 13 and 14). The amplification system is shown in table 5.

[0163] Table 5 MGC2 gene amplification system

[0164]

[0165]

[0166] The reaction conditions were: pre-denaturation at 95°C for 5 minutes; denaturation at 94°C for 45 seconds, annealing at 54°C for 45 seconds, extension at 72°C for 1 minute, 35 cycles; extension at 72°C for 10 minutes.

[0167] The PCR product is subjected to gel electrophoresis to verify the size of the target gene, such as Figure 4 As shown, the target ba...

Embodiment 3

[0179] Example 3 Construction and identification of transfer vector pF-MGC3

[0180] 1. MGC3 gene amplification and purification The codon-optimized MGC3 gene (SEQ ID NO: 5) was synthesized in Nanjing GenScript Company and cloned into the pUC17 vector to obtain the pUC-MGC3 plasmid vector. The pUC-MGC3 plasmid was used as a template, and MGC3-F and MGC3-R were used as upstream and downstream primers for PCR amplification (the gene sequences of MGC3-F and MGC3-R are shown in SEQ ID NO. 15 and 16). The amplification system is shown in Table 9.

[0181] Table 9 MGC3 gene amplification system

[0182]

[0183] The reaction conditions were: pre-denaturation at 95°C for 5 minutes; denaturation at 94°C for 45 seconds, annealing at 54°C for 45 seconds, extension at 72°C for 1 minute, 35 cycles; extension at 72°C for 10 minutes.

[0184] The PCR product is subjected to gel electrophoresis to verify the size of the target gene, such as Figure 7 As shown, the target band appeared ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides an immune composition and a subunit vaccine. The immune composition includes a protein selected from one or any combination of two or more of the following: using SEQ ID NO: 1 or 3 or The nucleic acid molecule of 5 or 7 or 9 or the Mycoplasma gallisepticum-related protein encoded by the nucleic acid molecule 95% or more identical to the nucleotide sequence of SEQ ID NO: 1 or 3 or 5 or 7 or 9. The vaccine uses eukaryotic expression, the antigenicity and immunogenicity of the product are similar to natural proteins, the expression level is high, the immunogenicity is strong, the protective effect is good, and it has no pathogenicity to chickens, and the vaccine of the present invention can pass biological reactions It can be prepared by large-scale serum-free suspension culture, while greatly reducing the cost of vaccine production.

Description

technical field [0001] The application relates to the technical field of animal immunization drugs, in particular to a preparation method and application of a novel genetic engineering vaccine of Mycoplasma gallisepticum. Background technique [0002] Mycoplasma Galliscepticum (MG) infection is a kind of respiratory disease in chickens, which mainly causes chronic respiratory disease, airsacculitis and sinusitis. The clinical manifestations are mainly cough, runny nose, rales when breathing, and mouth breathing in severe cases. According to statistics, after Mycoplasma gallisepticum infects the flock, the weak chick rate of chicks increases by about 10%, the laying rate of laying hens decreases by 10%-20%, the body weight of broilers decreases by 38%, the slaughter period is prolonged, and the feed conversion rate decreases by 21%. %, and can indirectly cause a lot of drug expenses, is one of the important diseases that endanger the chicken industry. [0003] Mycoplasma gal...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K39/02A61P31/04
CPCA61K39/0241A61P31/04A61K2039/552A61K2039/523
Inventor 曹文龙孔迪滕小锘易小萍张大鹤
Owner 苏州沃美生物有限公司